Villers-lès-Nancy, 10 October 2011 ­ 18:30 (CET)
PRESS RELEASE
FINALISATION OF ACQUISITION OF HOLDINGS IN DOMEDIC GROUP INC.

Canadian designer of innovative products for health
The PHARMAGEST Group, French leader in pharmacy information technology, is strengthening its development policy, aimed at consolidating its position as leader in the pharmacy information technology market by announcing this evening that it has acquired a minority shareholding in the Canadian start-up DOMEDIC Group Inc. This acquisition of a minority shareholding (35%) is completed with the creation of Domedic Europe S.A., of which the PHARMAGEST Group is a majority capital shareholder, at a level 65 %.
Pursuing development in innovative services and technological areas linked to health.

In accordance with its external growth strategy, PHARMAGEST INTERACTIVE has today strengthened its commitment with the finalisation of its acquisition of holdings in DOMEDIC Group Inc. (Company under Canadian law). This acquisition has been carried out by means of subscription to an increase in capital.

Operating in France, Belgium and Luxembourg, PHARMAGEST INTERACTIVE is thus pursuing the reinforcement of its product range in innovative health-related services.

DOMEDIC Group Inc.: designer of technological products supporting observance of medical treatment.

Located in Quebec (Canada), DOMEDIC Group Inc. is a young start-up created in 2006 by Benoit Demers and
Camille Lapierre.

DOMEDIC Group Inc. has as its mission, the improvement of quality of life for people suffering health problems that require regular medical treatment. In this way, DOMEDIC Group Inc. is developing products to support people who are aware their good health relies on the importance of strict monitoring of their medical treatment.

A founding project in perfect synergy with the PHARMAGEST Group’s historic commitment to monitoring observance by pharmacists.
The emergence of increased needs in the area of medication administered both to chronically ill patients and elderly people has given birth, from the founders of DOMEDIC, to the idea of a device that could compensate for risks linked to iatrogenic accidents and/or errors in observance.

For his part, because the pharmacist has numerous opportunities to take part in informing and educating patients and because the scope of his tasks has developed considerably in the context of the HPST Law of July 2009, the PHARMAGEST Group is developing solutions intended to support him in his advisory and preventative role towards his patients.

Therefore this acquisition of holdings underlines the continuity of the PHARMAGEST Group’s strategy.

Furthermore, it will enable it to complete its range of information technology products aimed at supporting patients suffering from chronic illnesses, to optimise monitoring of their treatment and improve observance.

Creation of DOMEDIC Europe
Furthermore, the partnership that links PHARMAGEST INTERACTIVE to DOMEDIC Group Inc. is made solid in
Europe by the creation of Domedic Europe. PHARMAGEST INTERACTIVE is the majority shareholder with 65% of the capital.
Based in Villers-lès-Nancy, Domedic Europe holds exclusive distribution rights for DOMEDIC Group Inc.’s products for Europe under a distribution agreement and brand licence entered into with DOMEDIC Group Inc.

In addition, PHARMAGEST INTERACTIVE has signed a distribution rights transfer agreement with DOMEDIC
Europe for France, Belgium and Luxembourg.

Télécharger le communiqué
!:!iframe http://www.nextnews.fr/upload/fr/nextnews%5Fpharmagest%5Finteractive%5Ffinalisation%5Fof%5Facquisition%5Fof%5Fholdings%5Fin%5Fdomedic%5Fgroup%5Finc%5F56873%2EPDF!:!

En partenariat avec NextNews